David Baltimore - Net Worth and Insider Trading
David Baltimore Net Worth
The estimated net worth of David Baltimore is at least $10 Million dollars as of 2024-09-20. David Baltimore is the Director of Amgen Inc and owns about 31,159 shares of Amgen Inc (AMGN) stock worth over $10 Million. Details can be seen in David Baltimore's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Baltimore has not made any transactions after 2017-05-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Baltimore
David Baltimore Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Baltimore owns 3 companies in total, including Regulus Therapeutics Inc (RGLS) , Immune Design Corp (IMDZ) , and Amgen Inc (AMGN) .
Click here to see the complete history of David Baltimore’s form 4 insider trades.
Insider Ownership Summary of David Baltimore
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RGLS | Regulus Therapeutics Inc | 2012-10-04 | director |
IMDZ | Immune Design Corp | 2019-04-02 | director |
AMGN | Amgen Inc | 2017-05-31 | director |
David Baltimore Latest Holdings Summary
David Baltimore currently owns a total of 1 stock. David Baltimore owns 31,159 shares of Amgen Inc (AMGN) as of May 31, 2017, with a value of $10 Million.
David Baltimore Form 4 Trading Tracker
According to the SEC Form 4 filings, David Baltimore has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 3,700 shares on May 31, 2017, which brought David Baltimore around $569,541.
Insider Trading History of David Baltimore
- 1
David Baltimore Trading Performance
David Baltimore Ownership Network
David Baltimore Owned Company Details
What does Regulus Therapeutics Inc do?
Who are the key executives at Regulus Therapeutics Inc?
David Baltimore is the director of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Sr. VP & General Counsel Christopher Ray Aker , Chief Operating Officer Joseph P Hagan , and Chief Financial Officer Crispina Calsada .
Regulus Therapeutics Inc (RGLS) Insider Trades Summary
Over the past 18 months, David Baltimore made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Crispina Calsada , and a net sale of 5,468 shares made by Christopher Ray Aker .
In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.
Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regulus Therapeutics Inc Insider Transactions
David Baltimore Mailing Address
Above is the net worth, insider trading, and ownership report for David Baltimore. You might contact David Baltimore via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.